Video
Become a Member to Save

Dr Suzy Elcombe's Post-ESID 2022 takeaways

Dr Suzy Elcombe, Consultant Immunologist at The Royal Victoria Infirmary, Newcastle-upon-Tyne with Dr Ariharan Anantharachagan, Consultant Immunologist at Lancashire Teaching Hospitals, Preston, will be discussing her two chosen topics from ESID 2022 and how these might impact on the management and care of immunodeficiency.

Topics chosen:

1. T-bet (high) CD21 (low) B cells in CVID; Klaus Warnatz

2. CVID, Inflammatory pathways and immune dysregulation; Charlotte Cunningham Rundles

Primary Immunodeficiency
Allied Professional
Consultant
FY1/FY2
General Practitioner
Nurse
Specialist Nurse
ST3+
Clinical Immunology
All Content
Contribute

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard

Adverse events should also be reported to Takeda UK Ltd. at: AE.GBR-IRL@takeda.com

Rare Disease Hub is for UK healthcare professionals only. This website has been initiated and developed by Takeda.

Copyright © 2022 Takeda UK Ltd.

 

C-ANPROM/GB/IG/0192

January 2023